天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 767-15-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 767-15-7
Chemical Structure| 767-15-7
Structure of 767-15-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 767-15-7 ]

Related Doc. of [ 767-15-7 ]

Alternatived Products of [ 767-15-7 ]
Product Citations

Product Details of [ 767-15-7 ]

CAS No. :767-15-7 MDL No. :MFCD00006102
Formula : C6H9N3 Boiling Point : -
Linear Structure Formula :(C4HN2)(NH2)(CH3)2 InChI Key :IDQNBVFPZMCDDN-UHFFFAOYSA-N
M.W : 123.16 Pubchem ID :13021
Synonyms :

Calculated chemistry of [ 767-15-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.37
TPSA : 51.8 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 0.67
Log Po/w (WLOGP) : 0.68
Log Po/w (MLOGP) : 0.06
Log Po/w (SILICOS-IT) : 1.06
Consensus Log Po/w : 0.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.52
Solubility : 3.73 mg/ml ; 0.0303 mol/l
Class : Very soluble
Log S (Ali) : -1.33
Solubility : 5.7 mg/ml ; 0.0463 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.02
Solubility : 1.17 mg/ml ; 0.00951 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 767-15-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 767-15-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 767-15-7 ]
  • Downstream synthetic route of [ 767-15-7 ]

[ 767-15-7 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 767-15-7 ]
  • [ 4214-57-7 ]
YieldReaction ConditionsOperation in experiment
83% With N-Bromosuccinimide In acetonitrile at 20℃; for 3 h; Inert atmosphere 2-Amino-5-bromo-4,6-dimethylpyrimidine (3):; To a stirred solution containing 4.3 lg (34.75 mmol) of 2-amino-4,6-dimethylpyrimidine (2) in 150 mL of acetonitrile were added 6.15g (52.12 mmol) of N-bromosuccinimide. The reaction mixture was stirred at room temperature under argon atmosphere for 3 h. The formed precipitate was filtered and dried to afford the expected product as a white solid: yield 5.93g (83percent).1H-NMR(CDC13) δ 5.19 (br, 2H), 2.44 (s, 6H);13C-NMR (CDC13) δ 166.28, 160.73, 109.60, 24.70.
83% With N-Bromosuccinimide In acetonitrile at 23℃; for 3 h; Inert atmosphere To a stirred solution containing 4.31 g (34.8 mmol) of 2-amino-4,6-dimethylpyrimidine (4) in 150 mL of acetonitrile was added 6.15 g (52.1 mmol) of N-bromosuccinimide. The reaction mixture was stirred at 23 °C for 3 h. The formed precipitate was filtered and dried to afford 5 as a colorless solid: yield 5.93 g (83percent); mp 183-185 °C; silica gel TLC Rf 0.15 (2:1 ethyl acetate/hexanes); 1H NMR (CDCl3) δ 2.44 (s, 6H) and 5.19 (br s, 2H); 13C NMR (CDCl3) δ 24.7, 109.6, 160.7 and 166.3; mass spectrum (APCI), m/z 201.9982 (M+H)+ (C6H9N3Br requires 201.9980).
Reference: [1] Patent: WO2011/103536, 2011, A1, . Location in patent: Page/Page column 35-37
[2] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 8, p. 608 - 613
[3] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 4, p. 969 - 978
[4] Synthetic Communications, 1991, vol. 21, # 7, p. 901 - 906
[5] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 20, p. 5139 - 5143
[6] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 11, p. 3980 - 3986
[7] Chemische Berichte, 1938, vol. 71, p. 87,99
[8] Biochemical Journal, 1951, vol. 48, p. 394,395
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 767-15-7 ]

Amines

Chemical Structure| 108-52-1

[ 108-52-1 ]

4-Methylpyrimidin-2-amine

Similarity: 0.82

Chemical Structure| 5734-71-4

[ 5734-71-4 ]

4-Bromo-6-methylpyrimidin-2-amine

Similarity: 0.75

Chemical Structure| 4214-57-7

[ 4214-57-7 ]

2-Amino-5-bromo-4,6-dimethylpyrimidine

Similarity: 0.75

Chemical Structure| 36314-98-4

[ 36314-98-4 ]

2-Amino-4-cyanopyrimidine

Similarity: 0.72

Chemical Structure| 1193-74-4

[ 1193-74-4 ]

4,5-Dimethylpyrimidin-2-amine

Similarity: 0.72

Related Parent Nucleus of
[ 767-15-7 ]

Pyrimidines

Chemical Structure| 1558-17-4

[ 1558-17-4 ]

4,6-Dimethylpyrimidine

Similarity: 0.86

Chemical Structure| 108-52-1

[ 108-52-1 ]

4-Methylpyrimidin-2-amine

Similarity: 0.82

Chemical Structure| 5734-71-4

[ 5734-71-4 ]

4-Bromo-6-methylpyrimidin-2-amine

Similarity: 0.75

Chemical Structure| 4214-57-7

[ 4214-57-7 ]

2-Amino-5-bromo-4,6-dimethylpyrimidine

Similarity: 0.75

Chemical Structure| 74502-82-2

[ 74502-82-2 ]

(6-Methylpyrimidin-4-yl)methanol

Similarity: 0.75

; ;